Showing results 1 to 2 of 2
| Issue Date | Title | Journal Title |
|---|---|---|
| 2025 | Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA | JOURNAL OF THORACIC ONCOLOGY |
| 2025 | Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC | NEW ENGLAND JOURNAL OF MEDICINE |